Today: 6 February 2026
Subscribe
Browse Category

OTC:AFJK News 11 December 2025

Biggest Stock Losers Today: Oracle’s AI Shock and Micro‑Cap Meltdowns Rock the U.S. Market (Dec. 11, 2025)

Biggest Stock Losers Today: Oracle’s AI Shock and Micro‑Cap Meltdowns Rock the U.S. Market (Dec. 11, 2025)

As Wall Street moves past the Federal Reserve’s latest interest‑rate cut, traders are staring at a very different story on their screens today: a cluster of heavy losers across U.S. stocks, led by a double‑digit plunge in Oracle and spectacular collapses in a handful of thinly traded micro‑caps. On Thursday, December 11, 2025, U.S. index futures are in the red…
11 December 2025
···········

Stock Market Today

  • AELIS.PA Dips 6.16% Pre-Market on EURONEXT Amid Clinical Trial and Valuation Concerns
    February 6, 2026, 2:31 AM EST. AELIS.PA shares fell 6.16% to €1.37 in early trading on EURONEXT with volume nearly double the average, reflecting heightened investor activity. The Bordeaux biotech faces pressure from upcoming clinical trial readouts and cash runway concerns. Despite trading above its 50- and 200-day moving averages, AELIS.PA reports negative earnings per share of -€0.64 and a price-to-sales ratio of 8.01, signaling stretched valuation for a small-cap biotech. Its debt-to-equity ratio stands at 1.13, pointing to rising leverage. The Meyka AI model assigns a HOLD rating with a fair value estimate of €3.06. Investors should consider risks tied to trial delays, binary outcomes, and sector volatility within healthcare, where peers command substantially higher price-to-earnings ratios.
Go toTop